EDCTP

AcronymDefinition
EDCTPEuropean-Developing Countries Clinical Trial Partnership
References in periodicals archive ?
"I am delighted that today, alongside our partners and South Africa, we are launching a second phase of the EDCTP programme.
I encourage all our stakeholders in Europe, Africa and elsewhere to take this early opportunity to give your feedback and help to inform the development of a future EDCTP programme.
Initial support for this research was made possible by funds from the EDCTP. The work described here was also supported by the National Institutes of Health (NIH) award number 1RO1 A1094586 (CHAMPS: Choices for Adolescent Methods of Prevention in SA).
Durban, South Africa: European and Developing Countries Clinical Trials Partnership (EDCTP), 2012.
Financial funding was provided by the European and Developing Countries Clinical trials Partnership (EDCTP) and the Institut Pasteur de Dakar.
"EDCTP is already engaging with pharmaceutical partners ranging from Small and Medium Enterprises (SMEs) to big pharma.
And he praised the progress achieved in medical research by the European & Developing Countries Clinical Trials Partnership (EDCTP).
Mark Nicol's research work is supported by the Wellcome Trust, European and Developing Countries Clinical Trials Partnership (EDCTP), National Institutes of Health (NIH), Medical Research Council (MRC), National Research Foundation (NRF) and PATH.
The European and Developing Countries Clinical Trials Partnership (EDCTP) is injecting over [euro]80m ($124m) into African medical research.
IAVI and the EDCTP also follow a due diligence approach in structuring their relationships with grantees and/or partners.
This European and Developing Countries Clinical Trials Partnership (EDCTP) is to be undertaken by the EU Member States (except Luxembourg) plus Norway, developing countries and industry in a joint effort to combat poverty-linked diseases.
The European & Developing Countries Clinical Trials Partnership (EDCTP) is seeking proposals to provide funding for clinical trials to be conducted in sub-Saharan Africa which aim to develop new or improved medicinal products (drugs and vaccines) or combinations thereof against pathogens from the WHO priority list that also fall within the scope of the EDCTP2 programme, specifically Campylobacter, Salmonella, Streptococcus pneumoniae, and Mycobacterium tuberculosis.